Member Info for Tyke68

Sorry August 20

ODD was feb 18

They do have fast track (two first one in feb 18). They also have ODD and PRDD. It will be interesting if they can get the drug passed in time to get a priority voucher or are they hoping the deadline will be extended?

Thanks

Afternoon Semantic

Have you any idea why they have called it phase2/3 results? Is it possible to expedite the phases eg using fast track?

Thanks

Plus we have the EAP which will hopefully expedite the time frames.

Fingers crossed

Thanks

Thanks onceaday

Great news for patients. Looking at their website we seem several years behind in the development process. https://www.kaziatherapeutics.com/site/pdf/be0e3a1c-e12c-44f4-bf3f-2d79f8829cf8/Kazia-Therapeutics-Announces-Phase-IIIII-Clinical-Trial-Results-for-Paxalisib-in-Glioblastoma.pdf

Worryingly their mcap is only $10m after the massive jump yesterday. I hope ours is worth many times that when we get to pass 2/3

Thanks.

Shrek

You have us good luck for the football. Can you work your magic for this share now please.

Have a good rest of the weekend

Thanks

I do wonder who oversees the twitter account, MS or semantic, sorry TB?

Is Mike too busy doing all the work and TB just looks for a comment from all the conferences Mike goes to?

But what we really need is all these leads and discussions at conferences been turned into sales. World leading technology at bargain basement mcap.

A month and half to the half year results, could we finally see some returns from the Bayer and GEHC links? Fingers crossed.

Thanks

It’s good to see MCW is directly named in it. Hopefully that will help in years to come with funding and customer awareness. The good news keeps coming and the price keeps falling. There will be a turning point, we just don’t know when.

Thanks for sharing Max

Plutuq

Well said, we have zero evidence of any sales or any bitcoins mined. We have continually being told testing and improvements etc but everything is theoretical not actual revenue producing. This has been going on for years now.

FG has been promising the world for so long now will he actually ever be satisfied and commit to selling the product or will customers actually finally commit to buying our products?

As normal, love to be proved wrong

Thanks

Thanks cautious

It does seem that semantic who wanted to discuss the business and move away from the shenanigans does not actually want to discuss the company. He keeps being very cryptic eg TB has sorted out succession but then doesn’t elaborate.

Oh well the communication was good whilst it lasted

Thanks

Semantic

There was only three trades of £500+ today.

Plus buys match the sells. There is no market as such hence rises and falls upon a few trades. People are just waiting for the next lot of news. However, a single good RNS can cause the sp to drop, people see the news, buys some shares and then sell when they make their 10% causing our sp to fall back, sometimes below the initial price. Also some people are scared that if they buy and the share price does rise there will be the large rounded sells again and nobody knows who is actually behind that. Hence hesitancy for people to invest

Most of us here are waiting for the transformative news and the effect that will have on investor confidence. Increased buys and sells to create a market as such.

Unfortunately I am not an accountant or businessmanto go into more details so these are more my layman’s views.

I keep asking you for your thoughts on the imaging side. If we have world leading products where are all the sales? Why don’t we have dedicated sales teams around the world knocking on doors. We only ever hear about word of mouth at conferences and occasionally twitter news. Whatever happened to the Asian sales etc? We keep being told lots of interest (45) but we only get told of occasional sales to hospitals and institutions. Surely this would be a way of raising funds for the drug trial. We understand we don’t have a dedicated code to charge insurance companies so why is that not a priority?

We have people on this board who have holdings of up to several million shares and those who have a lot less. Even though we are not significant holders we do want the company to succeed and speculate quite a lot on here because we are only fed scraps of information and do our own research looking for knowledge on the subject the best we can.

Thanks

Thanks Max

Interesting so few AI codes have been issued but they will be. Explains why it is taking so long to get.

Thanks

Semantic

We have all posted on possibilities for the drug trial but you haven’t given you thoughts on what may happen to the imaging side of the company. Will IQAI hold onto it, if the sales pick up, or will it be sold so as to fund the drug trial.

We don’t seem to have heard anything more about the 45 leads they were chasing up.

Thanks in advance

Max it might be worth sending to Mike to see if they can get involved.

Thanks for sharing

Remember what cautious posted yesterday, EAP approval has lead to 95% FDA drug approval. If that happens you will soon forget all this arguments. Think long term, a phase 2 company is worth more than phase 1 etc

Have a good weekend everybody

Thanks

Cautious

I like those odds

Thanks

Following on from what cautious said

Here is the data from the last 20 years, i wonder how many drugs received each of Fast Track, EAP, ODD, PRDD

“the share of FDA-approved drugs receiving each of the five special designations and review programs over the past 20 years. Two-thirds of new drugs received at least one special designation. Out of 666 new drug approvals, 367 (55%) received priority review, 279 (42%) orphan designation, 215 (32%) fast track, 124 (29%Footnote 4) breakthrough therapy, and 103 (15%) accelerated approval. The share of drugs receiving the orphan designation increased from 20% in 2003 to 54% in 2022. Similarly, the breakthrough therapy designation gained in popularity after its introduction in 2012, with 12% of drugs receiving the designation in 2013 and 35% in 2022.”

Thanks

A good article summing up all the dates for the trial.

https://firstwordpharma.com/story/5868444

Thanks

Evening

Just looking back at what I posted about QBT and came across this from 2022

“Hard facts

After reading all the RNSs yesterday I tried to think what are the actual verifiable facts for QBT. These are the facts I could think of:

- [ ] They have lodged a patent, which as of yet hasn’t been granted yet

- [ ] We won a litigation case but do not know how much we will actually collect or by when

- [ ] Operating loss of nearly €5m last year.

Excuse my ignorance but what other verifiable facts can people think of and I don’t mean what they say they are doing and going to be doing but without any evidence?

Everything else appears to be just supposition or rumour and not backed up by evidence or results.

I know I appear to be getting more cynical but as people keep saying DYOR and I do like dealing with facts.

Thank you

I hope you all have a good week and a RNS is released making my cynicism look stupid.”

Now apart from sort of knowing what the figure will be (no fixed amount after interest has been mentioned from what I have seen) what exactly has changed in nearly 2 years?

Have we sold a product or have we mined a single Bitcoin, no from what I have heard?

I am still invested and still want the company to succeed but those thinking this may be a quick profit, believe me it isn’t.

Fingers crossed I am made to look stupid hopefully sooner than another 2 years

Thanks

Same as normal with any good news. We go up then we drop below our initial price.

People buying it expecting it to rocket upwards, then is stays the same so they decide to cut their losses and we end up lower than we started.

Or as some believe FAB are selling again.

Thanks